Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities.
about
Herbimycins D-F, ansamycin analogues from Streptomyces sp. RM-7-15Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in miceUrsolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatmentAntitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs.Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996-2006)Co-infection with human immunodeficiency virus and tuberculosis in AsiaSynthesis and structure-activity relationship of 8-substituted protoberberine derivatives as a novel class of antitubercular agents.Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.Chemotherapeutic interventions against tuberculosisManaging TB in the 21st century: existing and novel drug therapies.Mycobacterium tuberculosis: drug resistance and future perspectives.Recent advances in antituberculous drug development and novel drug targets.Multidrug- and extensively drug-resistant TB in persons living with HIV.Design and construction of a DNA origami drug delivery system based on MPT64 antibody aptamer for tuberculosis treatmentDevelopment of new antituberculous agents based on new drug targets and structure-activity relationship.Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis.Antimycobacterial neolignans isolated from Aristolochia taliscana.Usefulness of Chinese Herbal Medicines as Host-Directed Therapeutics against Mycobacterial Infections: A Review.
P2860
Q28296599-706F0E36-94B7-46CA-ADD4-7BFCF35F3F6AQ34153280-3ECBBD67-9244-451D-8B4E-2C34B68B4A0BQ34271591-5E1FEBAD-C10C-47EE-A023-30B6A2A00110Q35010528-33DC2BDE-0FDE-4DCB-ACB2-768261E65BBFQ35411381-21568DD0-D71F-4F1B-9362-D37A710A28D7Q35727622-FE056C5D-7A7D-4307-943F-5D3AFE83F76DQ36074442-46B4EC65-D285-4B0B-A035-386B5B53575AQ37014832-084BE37A-CF3C-47CB-B183-1F4C79778C48Q37143499-7A217C1E-7860-44FD-A05C-79F13BF5755EQ37148764-243DBF16-3C5F-4DAA-B8CF-B4EB16AC5D20Q37362655-924F98CD-A429-4D98-A4E6-80D411A0A904Q37506524-5221D328-19BA-4DB9-BA3E-D3B42199FF6CQ37754884-A48C1AF5-4AD0-45E6-B1D5-A522B777FD32Q39226104-3404D6D6-49D9-48B5-849C-77154D8FEB4FQ39880559-14620C58-368C-48D7-A1B4-5B10125609A4Q40138610-2B3E4803-DFD8-46F6-9012-C3B12FD7B9EEQ42919818-06C44A1A-1B3B-4679-BA74-F74304A6C707Q44565103-A57E1ED7-0E4B-4FD1-B279-38BD2D6AD567Q47848547-20E250BA-8BF8-4571-B230-592D7B9ECB06
P2860
Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Current status of some antitub ...... vivo antimicrobial activities.
@ast
Current status of some antitub ...... vivo antimicrobial activities.
@en
type
label
Current status of some antitub ...... vivo antimicrobial activities.
@ast
Current status of some antitub ...... vivo antimicrobial activities.
@en
prefLabel
Current status of some antitub ...... vivo antimicrobial activities.
@ast
Current status of some antitub ...... vivo antimicrobial activities.
@en
P1476
Current status of some antitub ...... vivo antimicrobial activities.
@en
P2093
Haruaki Tomioka
P304
P356
10.2174/138161206778743646
P577
2006-01-01T00:00:00Z